Comparison of non-selective adrenocorticolysis with mitotane or trilostane for the treatment of dogs with pituitary-dependent hyperadrenocorticism. [electronic resource]
- The Veterinary record Dec 2007
- 805-9 p. digital
Publication Type: Journal Article
0042-4900
Adrenocortical Hyperfunction--drug therapy Age Factors Animals Antineoplastic Agents, Hormonal--adverse effects Body Weight--physiology Dihydrotestosterone--adverse effects Dog Diseases--drug therapy Dogs Female Kaplan-Meier Estimate Male Mitotane--adverse effects Proportional Hazards Models Treatment Outcome